Your browser doesn't support javascript.
loading
Nonclinical Safety Evaluation of scAAV8-RLBP1 for Treatment of RLBP1 Retinitis Pigmentosa.
MacLachlan, Timothy K; Milton, Mark N; Turner, Oliver; Tukov, Francis; Choi, Vivian W; Penraat, Jan; Delmotte, Marie-Hélène; Michaut, Lydia; Jaffee, Bruce D; Bigelow, Chad E.
Afiliação
  • MacLachlan TK; Preclinical Safety, Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Milton MN; Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Turner O; Preclinical Safety, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA.
  • Tukov F; Preclinical Safety, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA.
  • Choi VW; Ophthalmology Research, Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Penraat J; Preclinical Safety, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA.
  • Delmotte MH; Preclinical Safety, Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Michaut L; Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Jaffee BD; Ophthalmology Research, Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Bigelow CE; Ophthalmology Research, Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
Mol Ther Methods Clin Dev ; 8: 105-120, 2018 Mar 16.
Article em En | MEDLINE | ID: mdl-29359172

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Qualitative_research Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Qualitative_research Idioma: En Ano de publicação: 2018 Tipo de documento: Article